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a b s t r a c t
The colonisation of clinical and industrial surfaces with pathogenic microorganisms has prompted
increased research into the development of effective antibacterial and antifouling coatings. There is
evidence that implanted biomedical surfaces coated with metallic silver can be inactivated by physiolog-
ical fluids, thus reducing the bioactivity of the coating. In this work, we report the biofilm inhibition of
Staphylococcus epidermidisusinga roomtemperatureprocessedsilverdopedperfluoropolyether-urethane
coating. The release of silver ions from these fluoropolymers over a six-day period inhibited bacterial
encrustation – as observed by scanning electron microscopy (SEM). X-ray photoelectron spectroscopy
(XPS) analysis indicated differences in carbon, fluorine and sodium surface composition between silver
doped and undoped fluoropolymers after exposure to nutrient rich media. These silver doped perflu-
oropolyether coatings also exhibited antibacterial activity against methicillin-resistant Staphylococcus
aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii; suggesting poten-
tial use in preventing transmission of pathogenic and opportunistic microbes on environmental surfaces
in healthcare facilities. The broad-spectrum antibacterial activity of these silver release coatings may be
exploited on biomaterials surfaces to combat the development of resistant Gram-negative Enterobacteri-
aceae that can occur during prophylactic treatment for urinary tract infections.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Bacteria such as Staphylococcus aureus have shown adaptibility
to changing environments in the healthcare setting, but also more
recently in the wider community [1–3]. Opportunistic pathogens
such as S. aureus and Pseudomonas aeruginosa, along with other
bacteria, can develop resistance through an elaborate array of
mechanisms. These include modification of the target protein or
binding site, enzymatic destruction of antibacterial agents, active
efflux of drugs from the bacterial cell or by acquisition of genetic
material from other resistant strains [4,5]. The emergence of bacte-
rial resistance often occurs shortly after the introduction of a new
antibacterial agent. An increase in resistance can be observed by an
elevated minimum inhibitory concentration (MIC) of the antibac-
terial agent [6]. This can be exemplified by the rapid emergence of
Enterococcus faecium resistance to anti-VRE/MRSA antibiotics, such
as linezolid [7].
∗ Corresponding author. Tel.: +353 1 4024778; fax: +353 1 4024989.
E-mail address: declan.mccormack@dit.ie (D.E. McCormack).
The reduction in the number of available antibacterial therapies
for the treatment of multi-drug resistant pathogens, has resulted
in a reversion to older antimicrobial agents, such as silver [8]. In
medical terms, silver is the antimicrobial metal best known for
its broad-spectrum activity against intractable infectious microor-
ganisms, including antibiotic resistant strains [8]. The multiple
modes of action of silver include binding with cell DNA, inhibit-
ing enzymes that mediate respiration and reacting with sensitive
thiol groups on bacterial proteins – thereby destroying the normal
biological activity of the protein [9]. The antimicrobial properties
of nanosilver loaded filter paper against Escherichia coli have been
recently studied [10]. The use of medical device coatings as release
or delivery vehicles for these biocidal silver ions has received sig-
nificant attention recently. Silver ion release from sol–gel coatings
has demonstrated antibacterial activity against S. aureus and E. coli
[11–12]. Nanosilver coated fabric inhibited the growth of the Gram-
negative bacterium E. coli [13]. Silver coated PTFE surfaces have
shown antibacterial activity, but direct coating of silver onto a sur-
face canbe inactivatedbybiological anionswith subsequent surface
encrustation [14,15]. Previously reported studies have shown the
benefit of silver impregnation in place of metallic silver deposition
[16], although traditional techniques for the deposition or impreg-
nation of silver employ high temperature processing, which limits
0927-7765/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
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substrate choice and increases costs [11,16]. In addition, one of the
factors governing silver ion release from a coating matrix is the
hydrophilicity of the coating [17]. Therefore, coatings with purely
hydrophobic components will have limited water affinity and con-
sequently a low silver release. This route may be ineffective, as
coatings that release low levels of silver may select for resistance
[18].
Polyether polyurethanes are low friction, biocompatible, elas-
tomeric polymers that have been investigated as anti-fouling and
biomedical coatings [19]. However, they are prone to biodegra-
dation and environmental stress-cracking due to interactions
with lysomal oxygen-free radicals and transition metal ions from
implanted devices [20]. Polyether urethanes containing silver
nanoparticles have shown improved biostability due to the free
radical scavenging ability of the silver nanoparticles [21]. Modifi-
cation of these polymers with fluorocarbons has been reported to
improve biostability as fluorocarbons are stable against hydrolysis
and oxidation [22].
In this work, we present the preparation, antibacterial activity
and surface analysis of silver doped perfluoropolyether-urethane
coatings. Silver ion release from these fluorinated dispersions
exhibited significant antibacterial activity against MRSA, E. coli,
P. aeruginosa and Acinetobacter baumannii. SEM was employed to
examine the surfaces of the doped and undoped coatings after
exposure to a biofilm-positive strain of S. epidermidis. XPS sur-
face analysis provided information on the elemental and chemical
composition of the coatings before and after exposure to different
media. The surface composition of the silver doped fluoropoly-
mers did not display significant changes in surface chemistry after
six days bacterial exposure. In contrast, the blank fluoropolymers
showed increased surface carbon and sodium levels, with a reduc-
tion in fluorinated content. The antibacterial capacity of the silver
doped fluoropolymers was challenged by exchanging the nutrient
richmediumevery24h.After sixdaysbacterial exposure, the super-
natant broth still contained enough bio-active silver ions to inhibit
planktonic S. epidermidis. In summary, these roomtemperaturepro-
cessed coatings may be employed in reducing contamination and
biofouling on short-term indwelling devices and environmental
surfaces.
2. Experimental
Silver doped fluoropolymers were prepared by the addition of
a silver nitrate salt to an anionic perfluoropolyether (PFPE) ure-
thane polymer, Fluorolink® P56 (Mw ≈20,000, Solvay) [23]. 55mg
(0.3mmol) silver nitrate (Aldrich) was dissolved by sonication in
2.5ml (0.2mol) de-ionised water containing 2.5 g polyaziridine
cross-linker CX-100 (Neoresins). This solution was slowly added
to the anionic fluorinated dispersion (95g) under stirring. A sil-
ver nitrate free control was similarly prepared. The silver doped
fluoropolymers were prepared in amber glassware to prevent pho-
toreduction of the silver ions. The resulting silver doped and
undopedpolymerswere applied to pre-cleaned tin coated steel and
glass substrates using a 100m film applicator and cured at room
temperature for 4h, resulting in nominal film thickness of approxi-
mately 30m. The prepared coatings showed no tendency towards
delamination or cracking before or after testing.
2.1. Instrumentation
The release of silver from the coatings was determined by GF-
AAS using a Varian 110 Spectrometer equipped with a silver hollow
cathode lamp. Microanalysis of the coatings was assessed using a
Jeol 8600 scanning electron microscope (SEM). The samples were
mounted on stubs and gold coated for SEM imaging at 10KeV.
XPS analysis employed an ESCALAB Mk II spectrometer equipped
with a twin anode X-ray source was used to analyse the surface
composition (≈10nm) of the fluoropolymers and silver doped fluo-
ropolymers. The instrument was equipped with a twin anode X-ray
source (AlK/MgK) and an Alpha 110 analyser. In this work the
twin anode AlK X-ray source (h =1486.6 eV) was used at 300W
(15kV×20mA). Quantitative surface chemical analyses were cal-
culated from the high resolution, core level spectra following the
removal of a non-linear (Shirley) background. All spectrum binding
energies were referenced to the hydrocarbon C 1s peak at 285eV to
correct for electrostatic charging effects during acquisition. Sample
mounting for XPS analysis was achieved by fixing a specimen to a
VG sample stub using double sided adhesive tape.
2.2. Silver release
Silver doped perfluoropolyether coated glass substrates
(25 cm2) were immersed in 50ml of physiological buffered saline
(PBS) at 37 ◦C initially for 1h, followed by six successive 24h
immersion periods. Fresh media was used for each immersion
period. Silver values are expressed in ppb (g/L). The fluids were
collected after each immersion period and analysed using GF-AAS.
2.3. Antibacterial activity
The antibacterial activity of the silver doped and undoped
fluoropolymers, against a selection of Gram-positive and Gram-
negative strains, was determined using a modified version of the
Japanese standard (JIS Z2801). Thesebacterial strains includeMRSA
(clinical isolate) S. aureus (ATCC 25922), P. aeruginosa (ATCC 27853),
A. baumannii (clinical isolate) and a biofilm-positive strain of S. epi-
dermidis (CSF 41498). Stock cultures of the bacteria were grown on
plate count agar (PCA-3 w/v% tryptone, 1 w/v% glucose, 2.5 w/v%
yeast, 9 w/v% agar, Oxoid). The organisms were grown overnight
in nutrient rich broth to give a concentration of approximately
108 CFU/ml. These were diluted one in a hundred with maximum
recovery diluent (MRD – 1 w/v% peptone, 8.5 w/v% NaCl, Oxoid) to
give a working culture of approximately 106 CFU/ml. Doped and
undoped coatings (25 cm2) were inoculated with 400l of the
working bacterial cultures and incubated at 37 ◦C overnight. The
coatings were then agitated with MRD (20ml) in sterile stomacher
bags. To determine the number of colonies, the MRD was serially
diluted tenfold and the resultingdilutionsplated (100l) ontoplate
count agar (PCA) for overnight incubation at 37 ◦C.
2.4. Biofilm growth
Silver doped and undoped perfluorinated polymers were
applied to pre-cleaned tin panels and allowed to cure for 4h. Plas-
tic wells were glued to the surface of the coatings using an epoxy
fixative (Epofix) and left to cure for 24h (Fig. 1). 5ml of tryptic soy
broth (TSB – tryptone 17g/L, soy peptone 3g/L, NaCl 5 g/L, dipotas-
sium hydrogen phosphate 2.5 g/L, dextrose 2.5 g/L), supplemented
with 0.25% glucose was added to the wells. 50l of approximately
108 CFU/ml S. epidermidis (CSF 41498) culture was added to the glu-
cose modified TSB broth and the resulting bacterial broth poured
into the wells and incubated for 24h at 37 ◦C. The TSB medium
was removed and replaced with fresh glucose modified TSB every
24handsubsequently incubatedat37 ◦C. Thisprocesswas repeated
for six days. The daily exchange of nutrient rich media is useful in
challenging the antibacterial capacity of the coating over the six
days. Finally, themediumwasdecantedoff and the coatingswashed
twice with sterile water. SEM was used to examine the surface of
the coatings for the presence of any extraneous matter. Detailed
surface elemental and chemical composition of the fluoropolymer
coatings was obtained using XPS.
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Fig. 1. Non-cumulative release of silver into fresh PBS media from Ag doped fluo-
ropolymer (determined by GF-AAS).
3. Results and discussion
3.1. Silver release
The incorporation of silver salts into hydrophobic sol–gel coat-
ings has been reported to initially release high levels of silver ions,
followedbyamoregradual and sustained releaseprofile [12]. In this
work, the release of silver ions into PBS solution at 37 ◦C over six
days is depicted in Fig. 1. Initially after 1h, approximately 300ppb
was released into the PBS solution, followed by a more sustained
release profile for six days. As the first 6h after device implantation
is reported as being critical in reducing initial bacterial adhesion
[24], this initial high releaseof abroad-spectrumantibacterial agent
is favourable. XPS was employed to examine the surface composi-
tion of the coatings before and after exposure to external media.
XPS is a useful analytical tool in bioengineering for determining
the atomic composition of specific functional groups in the first
10nmof a surface coating. This techniquewas previously employed
to determine the surface composition of antibacterial furanones
[25]. XPS measurements of the silver doped coatings before and
after immersion in PBS indicated the appearance of a urethane
related peak at the coating surface following immersion (Fig. 2).
This specific peak at 532eV is associated with the carbonyl oxy-
gen of (–NH–(C O)–O–) [23]. This migration of polar species has
been previously reported with polyethylene glycol (PEG) modified
PFPE coatings [26]. Such polymers demonstrated surface adapt-
able properties when immersed in a polar medium such as water.
As PFPE molecules migrate to the air interface, the PEG molecules
also migrate. As a result, when the PEG modified PFPE polymer is
immersed in water the more polar PEG molecules stratify to the
air interface [26]. In this work, we observed a similar phenomenon
Fig. 2. O 1s XPS surface spectra of silver doped fluoropolymer before and after
immersion in PBS.
Fig. 3. Ag 3d XPS surface spectra of as-prepared Ag doped fluoropolymer coating.
with the stratification of the urethane species to the air-interface
after immersion in aqueous media. The presence of silver in the
as-prepared surface coating can be confirmed by the presence of
the peak at 368.2 eV [12]. The presence of silver in the coating was
confirmed by XPS analysis with a percentage atomic concentration
of 0.04% (Fig. 3). No surface silver was observed on the coating after
exposure to PBS. The daily exchange of anionic species such as chlo-
rides and phosphates in the PBS would have depleted the available
surface silver, by the possible formation of AgCl and Ag3PO4 pre-
cipitates on the coating surface [27]. No visible precipitates were
observed in the PBS solutions after silver release. No surface phos-
phoruswas observedbyXPS and thepercentage atomic sodiumand
chlorine was 3.2% and 0.91%, respectively.
3.2. Antibacterial activity
The release of silver ions from the perfluorinated coatings had
a significant antibacterial effect against MRSA (clinical isolate) S.
aureus (ATCC 25922), P. aeruginosa (ATCC 27853), A. baumanii (clin-
ical isolate) and a biofilm-positive strain of S. epidermidis (CSF
41498) (Fig. 4). Overnight incubation of the inoculated coatings
resulted in approximately 99% (>103 CFU/ml), reduction in bacterial
colonies compared to undoped samples after 24h. The broad-
spectrum activity suggests the use of these hygienic coatings in
preventing environmental contamination on hand rails, bedside
rails, door handles and other transmissible surfaces in healthcare
environments. This is important as patients who are infected with
healthcare and community associated microbes may shed bacte-
ria onto fomites such as those found in hospitals, nursing homes,
childcare facilities, prisons and public transport [28]. In addition, as
silver ion release is governedbywater diffusion through the coating
[17], the use of water as a cleaning agent, in-place of standard anti-
septics and detergents, may be sufficient to generate a bio-active
surface.
3.3. Biofilm growth
Biofilms are complex assemblages of microorganisms that bind
to host surfaces that can cause device failure and pathogenesis. Ses-
sile bacterial cells provide diffusion barriers to prophylactic treat-
ment by binding with antibiotics. Furthermore, the close proximity
of bacterial cells facilitates the spreading of antibiotic resistant
plasmids (extra-chromosomalmaterial) thus altering antimicrobial
susceptibility [29]. The bacterial cells that reside near the substra-
tum are in anoxic regions and are thus slow growing, leading to an
intrinsic tolerance to antibiotic dosage – relative to the aerobic cells
in the peripheral layers of the biofilm [30]. S. epidermidis is themost
common bacterium isolated from medical devices such as vascular
catheters, prosthetic implants and intrauterine devices [27]. Sev-
eral strategies have been investigated in preventing biofilm growth
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Fig. 4. Antibacterial activity of Ag doped perfluoropolyether coatings against (A) S. aureus (ATCC25922) (B) MRSA (clinical isolate) (C) P. aeruginosa (ATCC 27853) (D) A.
baumanii (clinicalisolate). Left plate: Silver doped fluoropolymer. Right plate: undoped fluoropolymer. (JIS Z 2801).
on indwelling biomaterials [31]. One of these techniques involves
the functionalisation of the indwelling surfaces; to include active
antibacterial agents on the biomaterial surface. Antibiotics func-
tion by targeting specific biomolecular pathways and as a result
have a propensity for the development of resistance to prophylac-
tic treatment. This emergence of antibiotic resistance has prompted
a resurgence in the use of biocidal metals, such as silver.
Due to the broad-spectrum activity at relatively low concentra-
tions, silver technology has been employed in various applications
such as medical devices [32], household appliances and water
treatment [33]. Low concentrations (<35ppb) are reported to be
bactericidal [34], whilst higher concentrations between 1ppm and
10ppm may cause damage to human cells, ranging from low
localised toxicity to conditions like argyria in higher doses (>4–6g
in the body) [35]. Histopathologic examination of silver coated
megaprostheses in humans showed no signs of local or systemic
side-effects at concentrations up to 1627ppb [36].
Silver impregnatedcathetershavebeen reported todemonstrate
superior inhibition of bacterial colonisation than antibiotic impreg-
nated catheters [37,38]. The effect of silver ions onbiofilmshas been
recently reported [39,40]. Addition of silver ions at a concentra-
tion of 50ppb to an existing biofilm had a diffusion limiting effect,
as sessile bacteria can sequester the silver ions into the anionic
polysaccharide components, reducing penetration and thus ren-
dering them inactive [40]. Therefore, it is crucial to inhibit biofilm
formation by reducing this initial surface bacterial adhesion [24].
In biological systems, the interaction between S. epidermidis bacte-
rial cells and surfaces are mediated by hydrophobic forces [41]. In
particular, the presence of hydrophobic chains in the fluoropolymer
may facilitate the microbial hydrophobic attraction of Staphylococ-
cal bacterial cells to the biomaterial surface. It has been reported
that a large quantity of microbial pathogens are dependent on
hydrophobic interactions for successful colonisation of host sub-
strates [42].
In this study, the effect of silver ion release on surface
encrustation can be observed in the SEM images in Fig. 5. The
blank perfluoropolyether-urethane coating is covered in adher-
ent bacterial deposits (Fig. 5a). Silver ion release from the doped
fluoropolymer reduced the colonisation of extraneous matter on
the coating surface (Fig. 5b). Additional XPS elemental and chem-
ical composition of the coatings indicated differences in surface
chemical composition (10nm) between the fluoropolymer and the
silver doped fluoropolymer after six days exposure to S. epider-
midis bacterial broth. The difference in percentage atomic carbon
(38.9% to 50.8%) (Fig. 6) and consequent reduction in atomic flu-
orine (35.2% to 17.5%) (Fig. 7) between silver doped and undoped
Fig. 5. SEM of fluoropolymer coating (a) and silver doped fluoropolymer (b) after six days S. epidermidis, bacterial broth incubation.
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Fig. 6. C 1s XPS surface spectra of fluoropolymer and silver doped fluoropolymer
after six days S. epidermidis bacterial broth incubation.
perfluorinated coating may be attributed to bacterial accumulation
on the fluoropolymer surface. The peak at 293.2 eV corresponding
to –C*F2–O–CF3 is present in the as-prepared fluoropolymer but
disappears after bacterial exposure (Fig. 6). Incorporation of a silver
salt in the fluoropolymer maintained this functional group at the
air-interface, by inhibiting planktonic bacterial adhesion and sub-
sequently reducing surface encrustation. Furthermore, there was a
reduction in percentage atomic sodium (Fig. 8), potassium, chlo-
rine and nitrogen on the surface of the silver doped fluoropolymer
coating (Table 1). The percentage of atomic silver present in the
as-prepared silver doped fluoropolymer was 0.04% but no surface
silver was detected by XPS post bacterial incubation, analogous to
PBS elution. In addition to the broad-spectrum antimicrobial activ-
ity against planktonic strains, silver ion elution reduced bacterial
colonisation on the coating surface. Furthermore, as biofilm frag-
ments may detach and the seed into surrounding fluids [43], it is
important to inhibit any free floating or planktonic bacteria. After
six days bacterial exposure, the supernatant broth still contained
enough bio-active silver ions to inhibit planktonic S. epidermidis
Fig. 7. F 1s XPS surface spectra of fluoropolymer and silver doped fluoropolymer
after six days S. epidermidis bacterial broth incubation.
Fig. 8. Na 1s XPS surface spectra of fluoropolymer and silver doped fluoropolymer
after six days S. epidermidis bacterial broth incubation.
Table 1
Summary of XPS data, before and after exposure to S. epidermidis broth for six days.
Coating type % XPS elemental composition
Ag C F O Na
Initial
fluoropolymer
0 29.2 52 17 0
Initial Ag
fluoropolymer
0.04 35.5 44.8 17 0
Fluoropolymer
after six days
bacterial
exposure
0 50.8 17.5 19 4.7
Ag fluoropolymer
after six days
bacterial
exposure
0 38.9 35.2 18 2.6
Fig. 9. Antibacterial activity of biofilm extraction media against planktonic S. epi-
dermidis (CSF 41498) after exposure to silver dopedfluoropolymer (a) fluoropolymer
(b).
(Fig. 9). Furthermore, these silver ion releasingcoatingsmaybeben-
eficial in reducing mineral precipitation and the associated biofilm
formation, by reducing the number of viable cells from the urease
producing Proteus mirabilis.
4. Conclusion
The tremendous resistance of biofilms to conventional pro-
phylactic agents has prompted a great deal of research on
biomaterial surfaces and coatings that can reduce bacterial
colonisation with subsequent device removal. In this paper,
we propose the use of a room temperature processed silver
release perfluoropolyether-urethane coating, in reducing the sur-
face colonisation on biomedical and environmental surfaces. XPS
analysis provided useful information on the surface composition
of the coatings before and after exposure to PBS and S. epidermidis
bacterial broth. The silver free fluoropolymer exhibited higher car-
bon and sodium content, with a consequent reduction in fluorine
content, in comparison to the silver containing fluoropolymer. The
release of silver ions from these fluorinated coatings demonstrated
antibacterial activity against MRSA, P. aeruginosa, A. baumannii and
S. epidermidis. There was approximately 99% reduction in the num-
berofbacterial colonies incomparison to thecontrolfluoropolymer.
The antibacterial capacity of these coatings was challenged by
the daily exchange of nutrient rich medium. These antibacterial
coatings can also be used to deliver alternative metal ions (Zn,
Cu) to inhibit fungal/algal growth and contamination on envi-
ronmental surfaces. As silver is a broad-spectrum antimicrobial,
these short-term indwelling coatings have the potential to com-
bat resistant Gram-negative Enterobacteriaceae that can occur after
fluoroquinolone, cephalosporin or glycopeptide administration for
urinary tract infections. The low temperature processing require-
ments of these silver release coatings makes them suitable for the
judicious protection of various surfaces against bacterial infection.
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